Literature DB >> 24623916

Prevalence of Helicobacter pylori, cytomegalovirus, and Chlamydia pneumoniae immunoglobulin seropositivity in coronary artery disease patients and normal individuals in North Indian population.

Rohit Tewari1, Vs Nijhawan2, Mn Mishra3, Puja Dudeja4, Tk Salopal5.   

Abstract

BACKGROUND: In present day atherosclerosis is perceived as a chronic inflammatory vascular condition and infectious diseases are believed to contribute to its pathophysiology. In this context, the microorganisms which are believed to play a role in the pathophysiology include Chlamydia pneumoniae, cytomegalovirus (CMV), and Helicobacter pylori.
METHOD: A case control study (retrospective) was conducted over a two-year period. The study population was divided into two groups with 200 individuals in each group. The first group comprised cases of coronary artery disease (CAD) and the second comprised healthy controls selected from the general population after matching for age and sex. Enzyme-linked immunosorbent assay (ELISA) was done for immunoglobulin (IgG) antibodies to H. pylori, C. pneumonia, and CMV. They were also evaluated for conventional risk factors including hypertension, diabetes, obesity, and dyslipidaemia. Epi Info™ version 6 six software was used for analysis of data. Odds ratio, χ(2) for trend and multiple logistic regression analysis were used to find out statistically significant results.
RESULTS: Seropositivity for H. pylori was present in 119 patients of CAD (59.5%) but it was present in only 76 controls (38%) (P = 0.001). There was a statistically significant association between seropositivity for H. pylori and CAD. There was no statistically significant association between C. pneumoniae and CMV seropositivity with CAD. Multiple logistic regression analysis was done with CAD as the outcome (dependent variable). The predictor covariates (independent) variables were seropositivity to H. pylori, C. pneumoniae, and CMV, hypertension, obesity, diabetes, and dyslipidaemia. It was found that seropositivity to H. pylori, hypertension, obesity, and dyslipidaemia were significant risk factors for CAD.
CONCLUSION: Our study shows an association between IgG antibody response to H. pylori and CAD. Multiple logistic regression analysis showed that this association was retained even on comparison with the other risk factors.

Entities:  

Keywords:  Chlamydia pneumoniae; Helicobacter pylori; coronary artery disease; cytomegalovirus

Year:  2012        PMID: 24623916      PMCID: PMC3862904          DOI: 10.1016/S0377-1237(11)60121-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  28 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.

Authors:  Murat V Kalayoglu; Peter Libby; Gerald I Byrne
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

3.  Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.

Authors:  Atul Kothari; V G Ramachandran; Piyush Gupta; Bharat Singh; Vibha Talwar
Journal:  J Health Popul Nutr       Date:  2002-12       Impact factor: 2.000

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

5.  Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography.

Authors:  Akira Tamura; Toshio Fujioka; Masaru Nasu
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

6.  Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore.

Authors:  Woon Puay Koh; Mark B Taylor; Kenneth Hughes; S K Chew; C W Fong; M C Phoon; K L Kang; Vincent T K Chow
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

7.  Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction.

Authors:  Kunihiro Kinjo; Hiroshi Sato; Hideyuki Sato; Issei Shiotani; Toshiya Kurotobi; Yozo Ohnishi; Eiji Hishida; Daisaku Nakatani; Hiroya Mizuno; Tatsuya Sasaki; Akio Kohama; Yukichi Abe; Hisaki Morita; Mitsuaki Kubo; Hiroshi Takeda; Masatsugu Hori
Journal:  Circ J       Date:  2002-09       Impact factor: 2.993

Review 8.  Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?

Authors:  William H Frishman; And Anjum Ismail
Journal:  Cardiol Rev       Date:  2002 Jul-Aug       Impact factor: 2.644

9.  Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina.

Authors:  M Kowalski; W Rees; P C Konturek; R Grove; T Scheffold; H Meixner; M Brunec; N Franz; J W Konturek; P Pieniazek; E G Hahn; S J Konturek; J Thale; H Warnecke
Journal:  Dig Liver Dis       Date:  2002-06       Impact factor: 4.088

10.  Changes of coronary risk factors after eradication of Helicobacter pylori infection.

Authors:  Ye-Hsu Lu; Hsueh-Wei Yen; Tsung-Hsien Lin; Chih-Hsin Huang; Kun-Tai Lee; Wen-Ming Wang; Deng-Chyang Wu; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  Kaohsiung J Med Sci       Date:  2002-06       Impact factor: 2.744

View more
  4 in total

Review 1.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

Review 2.  Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine.

Authors:  Nicole Borel; Cory Leonard; Jessica Slade; Robert V Schoborg
Journal:  Curr Clin Microbiol Rep       Date:  2016-02-03

3.  Gastric bacterial Flora in patients Harbouring Helicobacter pylori with or without chronic dyspepsia: analysis with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy.

Authors:  Verima Pereira; Philip Abraham; Sivaramaiah Nallapeta; Anjali Shetty
Journal:  BMC Gastroenterol       Date:  2018-01-26       Impact factor: 3.067

4.  Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Authors:  Ildikó Lantos; Valéria Endrész; Dezső Péter Virok; Andrea Szabó; Xinjie Lu; Tímea Mosolygó; Katalin Burián
Journal:  Biomed Res Int       Date:  2018-03-25       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.